Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: patient recorded as having no known allergies to drugs attending: chief complaint: hypertensive urgency major surgical or invasive procedure: hd history of present illness: mr. is a 39 yo man with dm1 c/b esrd and severe gastroparesis, htn, cad s/p stemi, and multiple line infections who is transferred from with abdominal pain and hypertensive urgency. patient was transferred to from yesterday at mn after developing severe abdominal pain, sweating, nausea, and vomiting, which he reported to be typical of his usual exacerbations of gastroparesis. at -nellesley er, 193/124, hr 97, t 99.9, rr 20, spo2 100% on ra. he received 1 amp d50 for hypoglycemia (bg 48), dilaudid 1 mg iv x4, ativan 1 mg iv, and morphine 4 mg iv. patient requested transfer to . past medical history: 1. diabetes mellitus type i - gastroparesis with chronic hospitalizations - esrd on hd since - autonomic dysfunction, frequent htn emergency & orthostatic hypotension - peripheral neuropathy 2. coronary artery disease - stemi in setting of cocaine, s/p bms to lad 3. aortic valve endocarditis () - in the context of coag neg staph bacteremia ( and ) and positive intravenous catheter tip had his hd catheter changed over a wire. 4. hypertension 5. history of line sepsis with coag negative staph , and priors with klebsiella and enterobacteremia 6. esophageal ulceration: h pylori neg, active esophagitis seen on egd , h/ - tear 7. history of substance abuse (cocaine, marijuana, alcohol) 9. history of thrombosed av fistula in lue , -tex in place 10. multiple line infections (mrse) and fungemia social history: patient has a prior history of tobacco and marijauna use, but he does not currently smoke. he has a prior history of alcohol abuse and has been sober for 9 years. he has a past history of cocaine use. he currently denies illicit drugs. currently lives with his mother and brothers. family history: father deceased of esrd and dm. mother aged 50's with hypertension. two sisters, one with diabetes. six brothers, one with diabetes. there is no family history of premature coronary artery disease or sudden death. physical exam: vitals: t: 98.2 bp: 162/100 p: 80 r: 12 sao2: 100% on 2l general: awake, alert, nad, pleasant, appropriate, cooperative. heent: ncat, perrl, eomi, no scleral icterus, mmm, no lesions noted in op neck: supple, no significant jvd or carotid bruits appreciated chest: tunnelled hd catheter with dressing intact on right anterior chest; lungs cta bilaterally, no wheezes, ronchi or rales cardiac: rr, nl s1 s2, murmur best heard at lusb, radiates to apex; no rubs or gallops appreciated abdomen: soft, nt, nd, hypoactive bowel sounds, no masses or organomegaly noted extremities: picc in rue without induration or surrounding erythema; no edema, 2+ radial, dp pulses b/l lymphatics: no cervical, supraclavicular, axillary or inguinal lymphadenopathy noted skin: no rashes or lesions noted. neurologic: alert, oriented x 3. able to relate history without difficulty. cranial nerves ii-xii intact. normal bulk, strength and tone throughout. no abnormal movements noted. no deficits to light touch throughout. no nystagmus, dysarthria, intention or action tremor. 2+ biceps, triceps, brachioradialis, patellar reflexes and 2+ ankle jerks bilaterally. plantar response was flexor bilaterally. pertinent results: labs at discharge: 05:37am white blood cells 5.0 k/ul 4.0 - 11.0 red blood cells 3.65* m/ul 4.6 - 6.2 hemoglobin 9.1* g/dl 14.0 - 18.0 hematocrit 31.7* % 40 - 52 mcv 87 fl 82 - 98 mch 24.8* pg 27 - 32 mchc 28.6* % 31 - 35 rdw 19.9* % 10.5 - 15.5 platelet count 288 k/ul 150 - 440 05:37am glucose 77 mg/dl 70 - 105 urea nitrogen 31* mg/dl 6 - 20 creatinine 9.6*# mg/dl 0.5 - 1.2 sodium 140 meq/l 133 - 145 potassium 4.3 meq/l 3.3 - 5.1 chloride 97 meq/l 96 - 108 bicarbonate 29 meq/l 22 - 32 anion gap 18 meq/l 8 - 20 calcium, total 9.9 mg/dl 8.4 - 10.2 phosphate 5.2* mg/dl 2.7 - 4.5 magnesium 1.7 mg/dl 1.6 - 2.6 iron 22* ug/dl 45 - 160 iron binding capacity, total 280 ug/dl 260 - 470 ferritin 151 ng/ml 30 - 400 transferrin 215 mg/dl 200 - 360 vancomycin 18.0 ug/ml 10 - 20 brief hospital course: patient is 39 yo man with dm1 c/b esrd - on hd - and severe gastroparesis, htn, cad s/p stemi, and multiple line infections who was transferred from nwh on with abdominal pain and hypertensive urgency. patient was transferred to nwh from nursing facility on after developing severe abdominal pain, sweating, n/v, consistent with usual exacerbations of gastroparesis. he requested transfer from nwh to . . during his most recent course in the ed and micu, patient received dilaudid, ativan, labetalol, hydralazine, clonidine and zofran. he was also on a labetalol gtt for a period of time - which was weaned off quickly and changed to regular po regiment. he had been having abdominal pain early through his hospital course, but it responded to dilaudid. hospital course by problem: . ** hypertensive urgency: initially started labetalol gtt which was discontinued shortly after arrival to icu. bp was then subsequently well controlled on home regiment: clonidine td, labetalol, lisinopril. . ** nausea/vomiting: secondary to chronic gastroparesis, slight elevation in alk phos but remainder of lfts and lipase wnl. controlled with iv ativan, dilaudid, reglan, zofran prn. regiment was changed to po ativan, dilaudid, reglan, zofran and diet was advanced to regular. . ** on hd: secondary to severe, uncontrolled dm and hypertension. on hd tues, thurs, saturday. continued calcium acetate, lanthanum and received iv iron replacement as thought to have iron deficiency anemia. . ** bacteremia: known mrse bacteremia for which he completed a course of vancomycin for possible endocarditis on . on more recent admission, patient grew 2/2 bottles with msse and was started on vancomycin per hd protocol. on was negative for evidence of endocarditis. his hd catheter was resided to a new subcutaneous tunneled catheter within the rij during that admission. the hd catheter tip grew mrse and he was continued on vanc at hd until end date . . ** fungemia: blood cultures from grew trichosporon species, and had finished his 10-day course of caspofungin prior to admission. day 1 = last day . . ** dm1: continued lantus 6 units qhs + lispro sliding scale. . ** cad s/p stemi: continued asa, , statin, beta-blocker. . ** peripheral neuropathy: continued neurontin. . ** anemia: chronic and secondary to esrd. currently at baseline hct 27-30. continued epo with hd. . medications on admission: aspirin 325 mg daily clopidogrel 75 mg daily atorvastatin 80 mg daily labetalol 100 mg tid lisinopril 20 mg daily, hold on days clonidine 0.3 mg/24 hr patch qfriday metoclopramide 5 mg po qidachs gabapentin 200 mg sun, mon, wed, fri gabapentin 100 mg tues, thurs, sat pantoprazole 40 mg calcium acetate 667 mg tid with meals lanthanum 1,000 mg tid with meals lantus 6 units qhs insulin lispro sliding scale hydromorphone 4 mg q6hrs prn lorazepam 1-2 mg q6-8hrs prn caspofungin 50 mg iv daily (start date , end date ) vancomycin qhd (end date ) discharge medications: 1. clopidogrel 75 mg tablet sig: one (1) tablet po daily (daily). 2. aspirin 325 mg tablet sig: one (1) tablet po daily (daily). 3. insulin glargine 100 unit/ml solution sig: six (6) units subcutaneous at bedtime. 4. clonidine 0.3 mg/24 hr patch weekly sig: one (1) patch weekly transdermal qwed (every wednesday). 5. atorvastatin 40 mg tablet sig: two (2) tablet po daily (daily). 6. gabapentin 100 mg capsule sig: one (1) capsule po 3x/week (tu,th,sa). 7. gabapentin 100 mg capsule sig: two (2) capsule po 4x/week (,mo,we,fr). 8. lanthanum 500 mg tablet, chewable sig: two (2) tablet, chewable po tid w/meals (3 times a day with meals). 9. b complex-vitamin c-folic acid 1 mg capsule sig: one (1) cap po daily (daily). 10. pantoprazole 40 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po q12h (every 12 hours). 11. labetalol 100 mg tablet sig: two (2) tablet po tid (3 times a day). disp:*180 tablet(s)* refills:*2* 12. lisinopril 20 mg tablet sig: one (1) tablet po daily (daily): please take after hemodialyis on days. disp:*30 tablet(s)* refills:*2* 13. metoclopramide 10 mg tablet sig: one (1) tablet po qidachs (4 times a day (before meals and at bedtime)). disp:*120 tablet(s)* refills:*2* 14. hydromorphone 4 mg tablet sig: one (1) tablet po q4h (every 4 hours) as needed. disp:*30 tablet(s)* refills:*0* 15. lorazepam 1 mg tablet sig: one (1) tablet po q6h (every 6 hours) as needed. disp:*30 tablet(s)* refills:*0* 16. vancomycin in dextrose 1 gram/200 ml piggyback sig: 1000 (1000) mg intravenous hd protocol (hd protochol) for 2 days: last day . discharge disposition: home discharge diagnosis: it is very important that you take all of your medications as directed and keep all your follow up appointments. you have been scheduled an appointment as below with the team. it is also very important that you attend this meeting in order to be further considered from transplantation. please do not miss appointments. if you develop abdominal pain, nausea or vomiting, chest pain, shortness of breath, facial swelling, pain at the site of your catheter or any other symptom that concerns you, please proceed to the emergency room as soon as possible. discharge condition: patient toleratin po well, bp well controlled, no nausea or vomiting discharge instructions: you were admitted with nausea and vomiting. you were treating with anti-nausea and pain medications which controlled your symptoms, and you have been able to eat a regular diet. followup instructions: it is very important that you keep the following appointment: provider: , center - non billing phone: date/time: 9:00 it is also very important that you continue to follow with dr. and attend . please do not miss s. please call to arrange an appointment with your primary care physician within two weeks of discharge. please call to arrange this appointment procedure: hemodialysis diagnoses: anemia in chronic kidney disease end stage renal disease coronary atherosclerosis of native coronary artery hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease bacteremia diabetes with neurological manifestations, type i [juvenile type], uncontrolled diabetes with renal manifestations, type i [juvenile type], uncontrolled gastroparesis 

Answer: The patient is high likely exposed to